Stereotactic Body Radiotherapy and Gemcitabine for Locally Advanced Pancreatic Cancer

Hypofractionated SBRT can be delivered quickly and effectively in patients with nonmetastatic, locally advanced, unresectable pancreatic cancer with acceptable side effects and minimal interference with gemcitabine chemotherapy.